Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Prostatic neoplasms and hypertrophy
ADR ID BADD_A03569
ADR Hierarchy
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.02      Prostatic neoplasms and hypertrophy
Description Not Available
MedDRA Code 10036966
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02174Testosterone undecanoate--
BADD_D02192Thalidomide--
BADD_D02214Ticagrelor--
BADD_D02224Tiotropium bromide--
BADD_D02236Tofacitinib--
BADD_D02237Tofacitinib citrate--
BADD_D02241Tolcapone--
BADD_D02297Triptorelin--
BADD_D02325Valdecoxib--
BADD_D02331Valsartan0.000079%
BADD_D02348Verapamil--
BADD_D02373Warfarin0.000028%
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide--
BADD_D02441Rasagiline--
BADD_D02443Tiotropium0.000690%
BADD_D02445Solifenacin--
BADD_D02464Fingolimod0.000651%
BADD_D02470Nintedanib--
BADD_D02487Baricitinib--
BADD_D02490Apalutamide--
BADD_D02539Calcium--
BADD_D02548Darolutamide--
BADD_D02567Lutetium lu-177 vipivotide tetraxetan--
BADD_D02586Radium ra-223 dichloride--
BADD_D02587Relugolix--
The 4th Page    First    Pre   4    Total 4 Pages